Co-founded and developed two biotechs – ZeClinics and ZeCardio Therapeutics – specializing in preclinical drug discovery and therapeutic advancements, with a focus on cardiovascular, toxicology and neural disorders. Led scientific teams, supervised innovative disease model development, and transitioned into business strategy roles to expand client portfolios and foster industry partnerships. Secured over 10M€ in public and private funding through strategic planning and proposal coordination (Included EIC Accelerator 2017). Held leadership roles, such as CSO at ZeClinics and ZeCardioTx and Vice President of AseBio, enhancing visibility of the biotechnology sector by promoting collaboration and strengthening industry alliances. Academic credentials include directing 5 industrial PhDs, a PhD in Molecular Biology from UAM and a Marie Curie postdoctoral Fellowship. Seeking opportunities to leverage expertise in biotech innovation, leadership and commercialization within the life sciences sector.